Global Hospital-acquired Infection Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Hospital-acquired Infection Diagnostics Market Size was estimated at USD 5205.76 million in 2023 and is projected to reach USD 7426.36 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.
This report provides a deep insight into the global Hospital-acquired Infection Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-acquired Infection Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-acquired Infection Diagnostics market in any manner.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Hospital-acquired Infection Diagnostics Market Size was estimated at USD 5205.76 million in 2023 and is projected to reach USD 7426.36 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.
This report provides a deep insight into the global Hospital-acquired Infection Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-acquired Infection Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-acquired Infection Diagnostics market in any manner.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hospital-acquired Infection Diagnostics Market
- Overview of the regional outlook of the Hospital-acquired Infection Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
1.2 Key Market Segments
1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hospital-acquired Infection Diagnostics Sales Sites, Area Served, Product Type
3.6 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
3.6.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2019-2024)
7 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2019-2024)
7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
8 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Hospital-acquired Infection Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-acquired Infection Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Hospital-acquired Infection Diagnostics Basic Information
9.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
9.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Hospital-acquired Infection Diagnostics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Advan DX
9.2.1 Advan DX Hospital-acquired Infection Diagnostics Basic Information
9.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
9.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
9.2.4 Advan DX Business Overview
9.2.5 Advan DX Hospital-acquired Infection Diagnostics SWOT Analysis
9.2.6 Advan DX Recent Developments
9.3 Abbott
9.3.1 Abbott Hospital-acquired Infection Diagnostics Basic Information
9.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
9.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
9.3.4 Abbott Hospital-acquired Infection Diagnostics SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Astrazeneca PLC
9.4.1 Astrazeneca PLC Hospital-acquired Infection Diagnostics Basic Information
9.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
9.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
9.4.4 Astrazeneca PLC Business Overview
9.4.5 Astrazeneca PLC Recent Developments
9.5 Bayer Schering Pharma LLC
9.5.1 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Basic Information
9.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
9.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
9.5.4 Bayer Schering Pharma LLC Business Overview
9.5.5 Bayer Schering Pharma LLC Recent Developments
9.6 Becton Dickinson And Company
9.6.1 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Basic Information
9.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
9.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
9.6.4 Becton Dickinson And Company Business Overview
9.6.5 Becton Dickinson And Company Recent Developments
9.7 Cepheid Inc.
9.7.1 Cepheid Inc. Hospital-acquired Infection Diagnostics Basic Information
9.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
9.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
9.7.4 Cepheid Inc. Business Overview
9.7.5 Cepheid Inc. Recent Developments
9.8 Roche AG
9.8.1 Roche AG Hospital-acquired Infection Diagnostics Basic Information
9.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
9.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
9.8.4 Roche AG Business Overview
9.8.5 Roche AG Recent Developments
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Hospital-acquired Infection Diagnostics Basic Information
9.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
9.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
9.9.4 Daiichi Sankyo Business Overview
9.9.5 Daiichi Sankyo Recent Developments
9.10 Hologic, Inc.
9.10.1 Hologic, Inc. Hospital-acquired Infection Diagnostics Basic Information
9.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
9.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
9.10.4 Hologic, Inc. Business Overview
9.10.5 Hologic, Inc. Recent Developments
10 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
10.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
10.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hospital-acquired Infection Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2025-2030)
11.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2025-2030)
11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
1.2 Key Market Segments
1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hospital-acquired Infection Diagnostics Sales Sites, Area Served, Product Type
3.6 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
3.6.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2019-2024)
7 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2019-2024)
7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
8 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Hospital-acquired Infection Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-acquired Infection Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Hospital-acquired Infection Diagnostics Basic Information
9.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
9.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Hospital-acquired Infection Diagnostics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Advan DX
9.2.1 Advan DX Hospital-acquired Infection Diagnostics Basic Information
9.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
9.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
9.2.4 Advan DX Business Overview
9.2.5 Advan DX Hospital-acquired Infection Diagnostics SWOT Analysis
9.2.6 Advan DX Recent Developments
9.3 Abbott
9.3.1 Abbott Hospital-acquired Infection Diagnostics Basic Information
9.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
9.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
9.3.4 Abbott Hospital-acquired Infection Diagnostics SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Astrazeneca PLC
9.4.1 Astrazeneca PLC Hospital-acquired Infection Diagnostics Basic Information
9.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
9.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
9.4.4 Astrazeneca PLC Business Overview
9.4.5 Astrazeneca PLC Recent Developments
9.5 Bayer Schering Pharma LLC
9.5.1 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Basic Information
9.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
9.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
9.5.4 Bayer Schering Pharma LLC Business Overview
9.5.5 Bayer Schering Pharma LLC Recent Developments
9.6 Becton Dickinson And Company
9.6.1 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Basic Information
9.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
9.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
9.6.4 Becton Dickinson And Company Business Overview
9.6.5 Becton Dickinson And Company Recent Developments
9.7 Cepheid Inc.
9.7.1 Cepheid Inc. Hospital-acquired Infection Diagnostics Basic Information
9.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
9.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
9.7.4 Cepheid Inc. Business Overview
9.7.5 Cepheid Inc. Recent Developments
9.8 Roche AG
9.8.1 Roche AG Hospital-acquired Infection Diagnostics Basic Information
9.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
9.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
9.8.4 Roche AG Business Overview
9.8.5 Roche AG Recent Developments
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Hospital-acquired Infection Diagnostics Basic Information
9.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
9.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
9.9.4 Daiichi Sankyo Business Overview
9.9.5 Daiichi Sankyo Recent Developments
9.10 Hologic, Inc.
9.10.1 Hologic, Inc. Hospital-acquired Infection Diagnostics Basic Information
9.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
9.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
9.10.4 Hologic, Inc. Business Overview
9.10.5 Hologic, Inc. Recent Developments
10 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
10.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
10.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hospital-acquired Infection Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2025-2030)
11.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2025-2030)
11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hospital-acquired Infection Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hospital-acquired Infection Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hospital-acquired Infection Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2022)
Table 10. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hospital-acquired Infection Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Hospital-acquired Infection Diagnostics Product Type
Table 13. Global Hospital-acquired Infection Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hospital-acquired Infection Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-acquired Infection Diagnostics Market Challenges
Table 22. Global Hospital-acquired Infection Diagnostics Sales by Type (K Units)
Table 23. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 24. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Hospital-acquired Infection Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Hospital-acquired Infection Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Application
Table 30. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 31. Global Hospital-acquired Infection Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Hospital-acquired Infection Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Hospital-acquired Infection Diagnostics Market Share by Application (2019-2024)
Table 35. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Hospital-acquired Infection Diagnostics Basic Information
Table 44. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
Table 45. Abbott Laboratories Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Hospital-acquired Infection Diagnostics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Advan DX Hospital-acquired Infection Diagnostics Basic Information
Table 50. Advan DX Hospital-acquired Infection Diagnostics Product Overview
Table 51. Advan DX Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Advan DX Business Overview
Table 53. Advan DX Hospital-acquired Infection Diagnostics SWOT Analysis
Table 54. Advan DX Recent Developments
Table 55. Abbott Hospital-acquired Infection Diagnostics Basic Information
Table 56. Abbott Hospital-acquired Infection Diagnostics Product Overview
Table 57. Abbott Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Hospital-acquired Infection Diagnostics SWOT Analysis
Table 59. Abbott Business Overview
Table 60. Abbott Recent Developments
Table 61. Astrazeneca PLC Hospital-acquired Infection Diagnostics Basic Information
Table 62. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
Table 63. Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Astrazeneca PLC Business Overview
Table 65. Astrazeneca PLC Recent Developments
Table 66. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Basic Information
Table 67. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
Table 68. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Schering Pharma LLC Business Overview
Table 70. Bayer Schering Pharma LLC Recent Developments
Table 71. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Basic Information
Table 72. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
Table 73. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Becton Dickinson And Company Business Overview
Table 75. Becton Dickinson And Company Recent Developments
Table 76. Cepheid Inc. Hospital-acquired Infection Diagnostics Basic Information
Table 77. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 78. Cepheid Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cepheid Inc. Business Overview
Table 80. Cepheid Inc. Recent Developments
Table 81. Roche AG Hospital-acquired Infection Diagnostics Basic Information
Table 82. Roche AG Hospital-acquired Infection Diagnostics Product Overview
Table 83. Roche AG Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Roche AG Business Overview
Table 85. Roche AG Recent Developments
Table 86. Daiichi Sankyo Hospital-acquired Infection Diagnostics Basic Information
Table 87. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
Table 88. Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Recent Developments
Table 91. Hologic, Inc. Hospital-acquired Infection Diagnostics Basic Information
Table 92. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 93. Hologic, Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Hologic, Inc. Business Overview
Table 95. Hologic, Inc. Recent Developments
Table 96. Global Hospital-acquired Infection Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Hospital-acquired Infection Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Hospital-acquired Infection Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Hospital-acquired Infection Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Hospital-acquired Infection Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hospital-acquired Infection Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hospital-acquired Infection Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hospital-acquired Infection Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Infection Diagnostics as of 2022)
Table 10. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hospital-acquired Infection Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Hospital-acquired Infection Diagnostics Product Type
Table 13. Global Hospital-acquired Infection Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hospital-acquired Infection Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-acquired Infection Diagnostics Market Challenges
Table 22. Global Hospital-acquired Infection Diagnostics Sales by Type (K Units)
Table 23. Global Hospital-acquired Infection Diagnostics Market Size by Type (M USD)
Table 24. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Hospital-acquired Infection Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Hospital-acquired Infection Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hospital-acquired Infection Diagnostics Sales (K Units) by Application
Table 30. Global Hospital-acquired Infection Diagnostics Market Size by Application
Table 31. Global Hospital-acquired Infection Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Hospital-acquired Infection Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Hospital-acquired Infection Diagnostics Market Share by Application (2019-2024)
Table 35. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Hospital-acquired Infection Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Hospital-acquired Infection Diagnostics Basic Information
Table 44. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
Table 45. Abbott Laboratories Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Hospital-acquired Infection Diagnostics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Advan DX Hospital-acquired Infection Diagnostics Basic Information
Table 50. Advan DX Hospital-acquired Infection Diagnostics Product Overview
Table 51. Advan DX Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Advan DX Business Overview
Table 53. Advan DX Hospital-acquired Infection Diagnostics SWOT Analysis
Table 54. Advan DX Recent Developments
Table 55. Abbott Hospital-acquired Infection Diagnostics Basic Information
Table 56. Abbott Hospital-acquired Infection Diagnostics Product Overview
Table 57. Abbott Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Hospital-acquired Infection Diagnostics SWOT Analysis
Table 59. Abbott Business Overview
Table 60. Abbott Recent Developments
Table 61. Astrazeneca PLC Hospital-acquired Infection Diagnostics Basic Information
Table 62. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
Table 63. Astrazeneca PLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Astrazeneca PLC Business Overview
Table 65. Astrazeneca PLC Recent Developments
Table 66. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Basic Information
Table 67. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
Table 68. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Schering Pharma LLC Business Overview
Table 70. Bayer Schering Pharma LLC Recent Developments
Table 71. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Basic Information
Table 72. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
Table 73. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Becton Dickinson And Company Business Overview
Table 75. Becton Dickinson And Company Recent Developments
Table 76. Cepheid Inc. Hospital-acquired Infection Diagnostics Basic Information
Table 77. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 78. Cepheid Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cepheid Inc. Business Overview
Table 80. Cepheid Inc. Recent Developments
Table 81. Roche AG Hospital-acquired Infection Diagnostics Basic Information
Table 82. Roche AG Hospital-acquired Infection Diagnostics Product Overview
Table 83. Roche AG Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Roche AG Business Overview
Table 85. Roche AG Recent Developments
Table 86. Daiichi Sankyo Hospital-acquired Infection Diagnostics Basic Information
Table 87. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
Table 88. Daiichi Sankyo Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Recent Developments
Table 91. Hologic, Inc. Hospital-acquired Infection Diagnostics Basic Information
Table 92. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
Table 93. Hologic, Inc. Hospital-acquired Infection Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Hologic, Inc. Business Overview
Table 95. Hologic, Inc. Recent Developments
Table 96. Global Hospital-acquired Infection Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Hospital-acquired Infection Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Hospital-acquired Infection Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Hospital-acquired Infection Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Hospital-acquired Infection Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Hospital-acquired Infection Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Hospital-acquired Infection Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hospital-acquired Infection Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-acquired Infection Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-acquired Infection Diagnostics Market Size by Country (M USD)
Figure 11. Hospital-acquired Infection Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hospital-acquired Infection Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hospital-acquired Infection Diagnostics Market Share by Type
Figure 18. Sales Market Share of Hospital-acquired Infection Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Hospital-acquired Infection Diagnostics by Type in 2023
Figure 20. Market Size Share of Hospital-acquired Infection Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Hospital-acquired Infection Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-acquired Infection Diagnostics Market Share by Application
Figure 24. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Hospital-acquired Infection Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Hospital-acquired Infection Diagnostics Market Share by Application in 2023
Figure 28. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hospital-acquired Infection Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hospital-acquired Infection Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2023
Figure 44. China Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hospital-acquired Infection Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hospital-acquired Infection Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Hospital-acquired Infection Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hospital-acquired Infection Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-acquired Infection Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Hospital-acquired Infection Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-acquired Infection Diagnostics Market Size by Country (M USD)
Figure 11. Hospital-acquired Infection Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Hospital-acquired Infection Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hospital-acquired Infection Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hospital-acquired Infection Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hospital-acquired Infection Diagnostics Market Share by Type
Figure 18. Sales Market Share of Hospital-acquired Infection Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Hospital-acquired Infection Diagnostics by Type in 2023
Figure 20. Market Size Share of Hospital-acquired Infection Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Hospital-acquired Infection Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-acquired Infection Diagnostics Market Share by Application
Figure 24. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Hospital-acquired Infection Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Hospital-acquired Infection Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Hospital-acquired Infection Diagnostics Market Share by Application in 2023
Figure 28. Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hospital-acquired Infection Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hospital-acquired Infection Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hospital-acquired Infection Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2023
Figure 44. China Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Hospital-acquired Infection Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hospital-acquired Infection Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hospital-acquired Infection Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hospital-acquired Infection Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hospital-acquired Infection Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Hospital-acquired Infection Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Application (2025-2030)
